Drugs / HIV-MAG vaccine
last change Oct 2016 re-read 2 minutes ago

HIV-MAG vaccine

Vaccine

Developed for
HIV infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01578889 May 2012 → Sep 2014 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HIV-MAG vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01578889
Modality Vaccine “HIV-MAG DNA vaccineNCT01578889